Vincent Bollors Media Influence Sparks Debate Over Democracy and EU Intervention Novartis Upgrades FullYear Outlook on Strong Portfolio Momentum SpaceX Successfully Launches Starship on Second Attempt Advancing DeepSpace Ambitions TikTok Goes Dark in US as Trump Signals Potential Intervention Market Uncertainty Looms Oura Health Files Confidentially for IPO Signaling Potential Public Market Debut Space Stocks Rally on Renewed SpaceX IPO Speculation ZVIA Q1 2026 Earnings NarrowerthanExpected Loss Lifts Shares 136 HHS Q2 2025 Earnings Narrowing PerShare Loss Amid Restructuring Efforts CEVA Q1 2026 Earnings EPS Surges Past Estimates Stock Declines Despite Beat Teva Q1 2026 Earnings Strong EPS Beat on Cost Discipline Shares Edge Higher OCFC Q1 2026 Earnings EPS Beats Expectations Amid Modest Share Decline FFIV Q1 2026 Earnings Strong EPS Beat Despite Stock Decline Virtus Global MultiSector Income Fund VGI Edges Higher Yield Support Remains Intact Mondelez International MDLZ Edges Higher as Support Holds But Resistance Caps Gains Beeline Holdings Inc BLNE Edges Lower Testing Proximity to Key Support Drugs Made In America Acquisition II Corp Unit DMIIU Holds Steady Near Trust Value Amid Low Volatility TruBridge TBRG Holds Steady at Key Inflection Point MYR Group Inc MYRG Surges 39 as Electrical Infrastructure Demand Drives Momentum Willis Lease Finance WLFC Holds Near Support After Modest Decline LTRYW Warrants Slip 421 at Penny Levels Key Support and Resistance Both at 001 Commercial Vehicle Group Inc CVGI Rallies as Shares Test Key Resistance Level Indigo Acquisition Corp Unit INACU Holds Steady at 1028 as SPAC Trading Remains Quiet Alibaba BABA Faces Resistance Near 136 as Shares Pull Back 119 Technical Levels in Focus VolitionRx Limited VNRX Gains Attention as TopRated Penny Stock Amid Wall Street Analyst Optimism MLYS Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Progress Continues Range Capital Acquisition Corp II RNGT Holds Near 10 Mark Amid Minimal Trading Activity Heartbeam Inc BEAT Q1 2026 Earnings EPS Surprises to the Upside Amid Revenue Data Absence Lexaria Bioscience Corp LEXX Q1 2026 Earnings EPS Beat by 38 Despite No Revenue Cyngn Inc CYN Q1 2026 Earnings EPS Beat Amid Zero Revenue Stock Edges Lower MSC Q4 2025 Earnings 011 EPS No Revenue Disclosure Stock Declines INLX Q1 2026 Earnings Significant EPS Miss Amidst Challenging Quarter BMNR Q1 2026 Earnings EPS Surprise as Company Reports Profitability DAWN Q4 2025 Earnings WiderThanExpected Loss As PreRevenue Biotech Advances Pipeline